Source: Pharmacogenomics. Unidades: FMRP, EERP
Subjects: POLIMORFISMO, HIPERTENSÃO, ÓXIDO NÍTRICO, NITRITOS, FARMACOGENÉTICA, PRÉ-ECLÂMPSIA
ABNT
LUIZON, Marcelo Rizzatti et al. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 23, n. 13, p. 713-722, 2022Tradução . . Disponível em: https://doi.org/10.2217/pgs-2022-0079. Acesso em: 20 ago. 2024.APA
Luizon, M. R., Pinto-Souza, C. C., Coeli-Lacchini, F. B., Lacchini, R., Cavalli, R. de C., & Sandrim, V. C. (2022). ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 23( 13), 713-722. doi:10.2217/pgs-2022-0079NLM
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2024 ago. 20 ] Available from: https://doi.org/10.2217/pgs-2022-0079Vancouver
Luizon MR, Pinto-Souza CC, Coeli-Lacchini FB, Lacchini R, Cavalli R de C, Sandrim VC. ARG2 single-nucleotide polymorphism rs3742879 affects plasma arginase 2 levels, nitric oxide formation and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2022 ; 23( 13): 713-722.[citado 2024 ago. 20 ] Available from: https://doi.org/10.2217/pgs-2022-0079